Business Description
Apollomics is a drug development company focused on finding new treatments for cancer. Founded in 2015 and based in Foster City, California, the company is currently testing several experimental medicines in clinical trials, targeting the biological signals that allow cancer cells to grow and spread. Its most advanced candidate, Vebreltinib, is in Phase 2 trials for lung cancer and other solid tumors, while additional treatments targeting brain cancer and other tumor types are in earlier stages of testing.
